Elpime TZ 250mg/31.25mg Injection
Marketer
Elixir Pharmacon
Salt Composition
Cefepime (250mg) + Tazobactum (31.25mg)
Overview Elpime TZ 250mg/31.25mg Injection
The dual-antibiotic injection, Elpime TZ 250mg/31.25mg, combats bacterial infections by inhibiting microbial proliferation. Administered only by a healthcare provider, this medication requires adherence to the prescribed schedule; complete the full course, even with symptom improvement. Typical side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions (redness, swelling, pain) may occur but usually resolve spontaneously. Severe side effects necessitate immediate medical attention, especially allergic reactions (rash, itching, swelling, respiratory distress). Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs.
Uses of Elpime TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Elpime TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not advised.
Common Side effects of Elpime TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Elpime TZ 250mg/31.25mg Injection:
Administering this medication requires a healthcare professional; your doctor or nurse will provide it. Self-medication is not advised.
How Elpime TZ 250mg/31.25mg Injection works:
Elpime TZ 250mg/31.25mg Injection unites cefepime, an antibiotic, with tazobactam, a beta-lactamase inhibitor. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam counters bacterial enzymes that would otherwise deactivate cefepime, thus broadening cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Elpime TZ 250mg/31.25mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Elpime TZ (250mg/31.25mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals have revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Elpime TZ 250mg/31.25mg is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Following administration of Elpime TZ 250mg/31.25mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Patients with kidney impairment should use Elpime TZ 250mg/31.25mg Injection cautiously; dosage modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Elpime TZ 250mg/31.25mg Injection in patients with liver impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary. Physician consultation is advised.
What if you forget to take Elpime TZ 250mg/31.25mg Injection :
Should you inadvertently skip a dose of Elpime TZ 250mg/31.25mg Injection, seek medical advice from your physician.
Facts to Know About Elpime TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently